Advance Care Planning in Adults With Congenital Heart Diseases: Current Practices, Preferences, and Needs of 8,281 Adults From 32 Countries

Read full text
Authors: Liesbet Van Bulck, Eva Goossens, Adrienne H. Kovacs, Koen Luyckx, Laila Akbar Ladak, M. B. C. Leye, Alexander Van De Bruaene, Ming Chern Leong, A Kaneva, Rafael Brolio Pavão, John Jairo Araujo, Navaneetha Sasikumar
+44 more H. Gabriel, Dejuma Yadeta Goshu, Chun‐Wei Lu, Junko Enomoto, M. Areias, Diamantis Kosmidis, Louise Coats, Anne Marie Valente, J. Moon, Magalie Ladouceur, Corina Thomet, Jamie L. Jackson, Camilla Sandberg, Edward Callus, Yuli Y. Kim, Birgitte Lykkeberg, Luis Alday, Charlène Bredy, Arwa Saidi, Fernando Baraona Reyes, Samuel Menahem, Michèle de Hosson, Z Mandelenakis, Christina Christersson, Ali Zaidi, Bengt Johansson, Brith Andresen, Jean-Claude Ambassa, Eva Sollén Mattsson, Andrew Constantine, Pascal Amedro, J. van Melle, Ari Cedars, Lucia Ortiz, Fatma Demir, Paul Khairy, Jonathan Windram, Judith Bouchardy, Maryanne Caruana, Susan M. Jameson, Vaikom S. Mahadevan, Lidija B. McGrath, Julius Chacha Mwita, Philip Moons
Cited by: 2
References: 39

Abstract

BACKGROUND: Adults with congenital heart disease (CHD) are at high risk of premature death, making advance care planning (ACP) crucial for aligning care with individual values and goals. Previous ACP research has focused primarily on the United States and Canada, highlighting the need for a global perspective. We aimed to describe the ACP practices, needs, and preferences of adults with CHD around the globe and to investigate associations with patient-related factors. METHODS: This cross-sectional study, part of the APPROACH-IS II project, assessed ACP preferences, needs, and practices by means of patient-reported surveys. Overall, 8281 patients with CHD (median age 32 years; 54% women; 15% mild, 58% moderate, 27% complex CHD) from 53 centres in 32 countries, spanning 6 continents, were included. RESULTS: More than one-half of participants (55%) reported speaking to their physician about how their health might be in the future and 9% had preferences being documented in a plan. According to 66% of patients, the best time to initiate ACP is early in the disease trajectory. Most patients indicated being relatively comfortable talking to their physician about their future health and about death. ACP varied widely across different countries, with the United States and Canada at the top of the class for most variables. CONCLUSIONS: When looking at global ACP practices, needs, and preferences, much room for improvement of ACP provision could be noticed. Also, a notable variation in ACP was observed worldwide. CLINICAL TRIAL REGISTRATION: NCT04902768.

Fields of Study & Subjects

Congenital Heart Disease Studies Transplantation: Methods and Outcomes Heart Failure Treatment and Management

Publication details

Journal / source
Canadian Journal of Cardiology
Publisher
Elsevier BV
Volume
42
Issue
6
Pages
1338–1348
Publication date
8 January 2026
Language
EN